Immune-related adverse events in hepatocellular carcinoma: organ-specific patterns and management approaches
{{output}}
Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide. The recent introduction of immune checkpoint inhibitors (ICIs) has transformed the therapeutic landscape of advanced HCC. Combination regimens such as atezolizumab plus beva... ...
